218 related articles for article (PubMed ID: 22795806)
41. P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer.
Dillon LM; Bean JR; Yang W; Shee K; Symonds LK; Balko JM; McDonald WH; Liu S; Gonzalez-Angulo AM; Mills GB; Arteaga CL; Miller TW
Oncogene; 2015 Jul; 34(30):3968-76. PubMed ID: 25284585
[TBL] [Abstract][Full Text] [Related]
42. Stereotactic radiosurgery (SRS) for brain metastases: a systematic review.
Nieder C; Grosu AL; Gaspar LE
Radiat Oncol; 2014 Jul; 9():155. PubMed ID: 25016309
[TBL] [Abstract][Full Text] [Related]
43. Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy.
Kocher M; Wittig A; Piroth MD; Treuer H; Seegenschmiedt H; Ruge M; Grosu AL; Guckenberger M
Strahlenther Onkol; 2014 Jun; 190(6):521-32. PubMed ID: 24715242
[TBL] [Abstract][Full Text] [Related]
44. CSCO expert consensus on the diagnosis and treatment of breast cancer brain metastasis.
Wang T; Chen J; Yang J; Fu M; Hua W; Jia W; Liu Y; Wang B; Yan M; Zhou J; Hao C; Chen J; Ou D; Jiang T; Mao Y; Jiang Z; ;
Transl Breast Cancer Res; 2022; 3():22. PubMed ID: 38751521
[TBL] [Abstract][Full Text] [Related]
45. Resection cavity dynamics and optimal timing of adjuvant stereotactic radiosurgery for resected brain metastases.
Rajkumar S; Liang Y; Shepard MJ; Williamson R; Yu A; Karlovits SM; Rodney EW
J Radiosurg SBRT; 2022; 8(4):247-255. PubMed ID: 37416330
[TBL] [Abstract][Full Text] [Related]
46. TME-targeted approaches of brain metastases and its clinical therapeutic evidence.
Khan IM; Khan SU; Sala HSS; Khan MU; Ud Din MA; Khan S; Hassan SSU; Khan NM; Liu Y
Front Immunol; 2023; 14():1131874. PubMed ID: 37228619
[TBL] [Abstract][Full Text] [Related]
47. Dosimetric investigation of whole-brain radiotherapy with helical intensity modulated radiation therapy and volumetric modulated arc therapy for scalp sparing.
Shirata R; Inoue T; Sugimoto S; Saito AI; Omura M; Minagawa Y; Sasai K
BJR Open; 2023; 5(1):20220037. PubMed ID: 37035770
[TBL] [Abstract][Full Text] [Related]
48. Sensitizing brain metastases to stereotactic radiosurgery using hyperbaric oxygen: A proof-of-principle study.
Hartford AC; Gill GS; Ravi D; Tosteson TD; Li Z; Russo G; Eskey CJ; Jarvis LA; Simmons NE; Evans LT; Williams BB; Gladstone DJ; Roberts DW; Buckey JC
Radiother Oncol; 2022 Dec; 177():179-184. PubMed ID: 36404528
[TBL] [Abstract][Full Text] [Related]
49. Stereotactic radiosurgery for post operative brain metastasic surgical cavities: a single institution experience.
Cantaloube M; Boucekine M; Balossier A; Muracciole X; Meyer M; Delsanti C; Carron R; Beltaifa YM; Figarella-Branger D; Regis J; Padovani L
Radiat Oncol; 2022 Sep; 17(1):160. PubMed ID: 36163026
[TBL] [Abstract][Full Text] [Related]
50. Stereotactic Radiosurgery to Prevent Local Recurrence of Brain Metastasis After Surgery: Neoadjuvant Versus Adjuvant.
McCutcheon IE
Acta Neurochir Suppl; 2021; 128():85-100. PubMed ID: 34191064
[TBL] [Abstract][Full Text] [Related]
51. Local failure after stereotactic radiosurgery (SRS) for intracranial metastasis: analysis from a cooperative, prospective national registry.
Asher AL; Alvi MA; Bydon M; Pouratian N; Warnick RE; McInerney J; Grills IS; Sheehan J
J Neurooncol; 2021 Apr; 152(2):299-311. PubMed ID: 33481148
[TBL] [Abstract][Full Text] [Related]
52. [Research Progress in the Treatment of Brain Metastases
from Non-small Cell Lung Cancer].
Han X; Li H
Zhongguo Fei Ai Za Zhi; 2020 Dec; 23(12):1087-1094. PubMed ID: 33357316
[TBL] [Abstract][Full Text] [Related]
53. A Dose-Response Model of Local Tumor Control Probability After Stereotactic Radiosurgery for Brain Metastases Resection Cavities.
Gui C; Grimm J; Kleinberg LR; Zaki P; Spoleti N; Mukherjee D; Bettegowda C; Lim M; Redmond KJ
Adv Radiat Oncol; 2020; 5(5):840-849. PubMed ID: 33083646
[TBL] [Abstract][Full Text] [Related]
54. Neuro-Oncology Practice Clinical Debate: stereotactic radiosurgery or fractionated stereotactic radiotherapy following surgical resection for brain metastasis.
Palmer JD; Greenspoon J; Brown PD; Johnson DR; Roberge D
Neurooncol Pract; 2020 Jun; 7(3):263-267. PubMed ID: 32537175
[TBL] [Abstract][Full Text] [Related]
55. The Relationship Between Tumor Volume and Timing of Post-resection Stereotactic Radiosurgery to Maximize Local Control: A Critical Review.
Yuan M; Behrami E; Pannullo S; Schwartz TH; Wernicke AG
Cureus; 2019 Sep; 11(9):e5762. PubMed ID: 31723521
[TBL] [Abstract][Full Text] [Related]
56. Operative and peri-operative considerations in the management of brain metastasis.
Sankey EW; Tsvankin V; Grabowski MM; Nayar G; Batich KA; Risman A; Champion CD; Salama AKS; Goodwin CR; Fecci PE
Cancer Med; 2019 Nov; 8(16):6809-6831. PubMed ID: 31568689
[TBL] [Abstract][Full Text] [Related]
57. Placement of
Greenwald J; Taube S; Yondorf MZ; Smith A; Sabbas A; Wernicke AG
J Contemp Brachytherapy; 2019 Aug; 11(4):356-360. PubMed ID: 31523237
[TBL] [Abstract][Full Text] [Related]
58. Hypofractionated Radiation Therapy for Large Brain Metastases.
Masucci GL
Front Oncol; 2018; 8():379. PubMed ID: 30333955
[TBL] [Abstract][Full Text] [Related]
59. Postoperative Cavity Stereotactic Radiosurgery for Brain Metastases.
Marchan EM; Peterson J; Sio TT; Chaichana KL; Harrell AC; Ruiz-Garcia H; Mahajan A; Brown PD; Trifiletti DM
Front Oncol; 2018; 8():342. PubMed ID: 30234013
[TBL] [Abstract][Full Text] [Related]
60. Postoperative local fractionated radiotherapy for resected single brain metastases.
Ayas AW; Grau S; Jablonska K; Ruess D; Ruge M; Marnitz S; Goldbrunner R; Kocher M
Strahlenther Onkol; 2018 Dec; 194(12):1163-1170. PubMed ID: 30218137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
